For Oncology Nurses: Endometrial Cancer — Proceedings from the 2026 Annual ONS Congress
About this episode
This episode discusses various aspects of endometrial cancer treatment and nursing considerations with expert guests.
Featuring perspectives from Dr Dana M Chase, Ms Sarah Karpen, Dr J Alejandro Rauh-Hain and Ms Jaclyn Shaver, moderated by Dr Chase, including the following topics: Introduction: Biology of Endometrial Cancer (EC) (0:00) First-Line Therapy for Advanced or Recurrent EC (14:15) Potential Benefits of PARP Inhibition Combined with Immunotherapy in Advanced EC (35:13) Role of Lenvatinib/Pembrolizumab in the Management of Progressive Advanced EC (57:48) Other Nursing Considerations in the Care of Patients with Advanced EC (1:17:28) NCPD information and select publications
People in this episode
Host: Dr Chase
Guests: Dr Dana M Chase, Ms Sarah Karpen, Dr J Alejandro Rauh-Hain, Ms Jaclyn Shaver
Topics covered
- Endometrial Cancer
- First-Line Therapy
- PARP Inhibition
- Immunotherapy
- Nursing Considerations
Keywords
- Endometrial Cancer
- Advanced EC
- PARP Inhibition
- Immunotherapy
- Nursing Care
Mentioned in this episode
Books & works: Endometrial Cancer
More episodes of Gynecologic Oncology Update
- Endometrial Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
- Ovarian Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
- Endometrial Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women’s Cancer
- Endometrial Cancer — Microlearning Activity 1: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women’s Cancer
- Endometrial Cancer — An Interview with Dr Floor J Backes
- For Oncology Nurses: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress
Explore listener stats, chart rankings, contacts and more on the Gynecologic Oncology Update podcast page.